CBPO China Biologic Products Holdings, Inc. Stock Quote

CBPO [NASD]

China Biologic Products Holdings, Inc.

Index	-	P/E	33.18	EPS (ttm)	3.56	Insider Own	45.59%	Shs Outstand	38.69M	Perf Week	-1.29%
Market Cap	4.59B	Forward P/E	22.04	EPS next Y	5.36	Insider Trans	0.00%	Shs Float	21.30M	Perf Month	-0.08%
Income	139.40M	PEG	2.75	EPS next Q	0.69	Inst Own	50.90%	Short Float	4.60%	Perf Quarter	-0.46%
Sales	514.40M	P/S	8.92	EPS this Y	6.30%	Inst Trans	7.46%	Short Ratio	5.83	Perf Half Y	11.60%
Book/sh	48.75	P/B	2.42	EPS next Y	11.12%	ROA	6.90%	Target Price	102.78	Perf Year	2.45%
Cash/sh	28.42	P/C	4.16	EPS next 5Y	12.05%	ROE	7.90%	52W Range	97.91 - 120.01	Perf YTD	0.08%
Dividend	-	P/FCF	18.82	EPS past 5Y	5.40%	ROI	8.00%	52W High	-1.51%	Beta	0.42
Dividend %	-	Quick Ratio	10.10	Sales past 5Y	15.70%	Gross Margin	64.90%	52W Low	20.72%	ATR	0.89
Employees	2269	Current Ratio	12.00	Sales Q/Q	1.80%	Oper. Margin	35.30%	RSI (14)	39.58	Volatility	0.73% 0.70%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-18.20%	Profit Margin	27.10%	Rel Volume	0.65	Prev Close	119.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 24 AMC	Payout	0.00%	Avg Volume	167.79K	Price	118.20
Recom	3.00	SMA20	-0.64%	SMA50	-0.24%	SMA200	5.15%	Volume	109,617	Change	-1.12%

Mar-11-19

Downgrade

Jefferies

Hold → Underperform

$67 → $62

Nov-05-18

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Aug-06-18

Downgrade

Credit Suisse

Outperform → Neutral

May-14-18

Downgrade

Jefferies

Buy → Hold

May-30-17

Initiated

Goldman

Neutral

Mar-01-16

Downgrade

Credit Suisse

Outperform → Neutral

Oct-08-15

Initiated

Credit Suisse

Outperform

Jul-09-15

Initiated

BofA/Merrill

Buy

$135

Jul-08-14

Reiterated

Aegis Capital

Buy

$50 → $55

Mar-14-14

Initiated

Oppenheimer

Outperform

$46

Nov-06-13

Downgrade

Aegis Capital

Buy → Hold

Mar-14-13

Reiterated

Aegis Capital

Buy

$22 → $28

May-13-10

Reiterated

Brean Murray

Buy

$19 → $20

Mar-26-10

Reiterated

Brean Murray

Buy

$15 → $19

Mar-01-21 08:00AM	China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire
Jan-25-21 08:44AM	China Biologic Announces Extraordinary General Meeting of Shareholders PR Newswire
Dec-16-20 10:36PM	Is CBPO A Good Stock To Buy Now? Insider Monkey
Nov-26-20 12:00AM	China Biologic Products Inc (CBPO) Q3 2020 Earnings Call Transcript Motley Fool
Nov-24-20 04:30PM	China Biologic Reports Financial Results for the Third Quarter of 2020 PR Newswire
Nov-20-20 07:37AM	The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger Benzinga
Nov-19-20 08:09AM	China Biologic Enters into Definitive Merger Agreement for Going Private Transaction PR Newswire
Nov-13-20 08:00AM	China Biologic Products to Report Third Quarter 2020 Financial Results PR Newswire
Oct-09-20 12:41PM	Hedge Funds Dipping Their Toes Into China Biologic Products Holdings Inc (CBPO) Insider Monkey
Aug-18-20 04:00PM	China Biologic Products Inc (CBPO) Q2 2020 Earnings Call Transcript Motley Fool
Aug-17-20 04:30PM	China Biologic Reports Financial Results for the Second Quarter of 2020 PR Newswire
Aug-16-20 08:30AM	The Week Ahead In Biotech: Spotlight On Gilead, BioMarin FDA Decisions, IPOs Benzinga
Aug-10-20 08:00AM	China Biologic Products to Report Second Quarter 2020 Financial Results PR Newswire
Jul-13-20 12:45PM	5 Profitable Companies With a Margin of Safety GuruFocus.com
Jun-30-20 11:18AM	5 Health Care Stocks Boosting Earnings GuruFocus.com
Jun-29-20 01:00AM	China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction PR Newswire
Jun-26-20 12:55PM	Hedge Funds Are Selling China Biologic Products Holdings Inc (CBPO) Insider Monkey
May-21-20 04:00PM	China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript Motley Fool
May-20-20 04:45PM	China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction PR Newswire
04:30PM	China Biologic Reports Financial Results for the First Quarter of 2020 PR Newswire
May-12-20 08:30AM	China Biologic Products to Report First Quarter 2020 Financial Results PR Newswire
Apr-05-20 07:44PM	Hedge Funds Are Buying China Biologic Products Inc (CBPO) Insider Monkey
Mar-12-20 05:00PM	China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019 PR Newswire
Mar-10-20 10:41AM	China Biologic, Suitor Are in Advanced Talks on Take-Private Bloomberg
Mar-03-20 08:30AM	China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results PR Newswire
Dec-20-19 07:02AM	7 Ideal Mid-Cap Stocks for a Diverse Portfolio InvestorPlace
Dec-16-19 05:42PM	5 Top-Performing Chinese Stocks in 2019 GuruFocus.com
Dec-12-19 09:51AM	Is China Biologic Products Inc (CBPO) A Good Stock To Buy? Insider Monkey
Dec-03-19 02:42PM	Hedge Funds Love Assured Guaranty (AGO) Way More Than These 4 Stocks Insider Monkey
Dec-02-19 02:57PM	7 Exciting Biotech Stocks to Buy Now InvestorPlace
Nov-15-19 10:09AM	The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval Benzinga
Nov-13-19 04:30PM	China Biologic Reports Financial Results for the Third Quarter of 2019 PR Newswire
Nov-05-19 07:01PM	China Biologic Bidder Seeks Over $1 Billion in Financing Bloomberg
Nov-04-19 08:30AM	China Biologic Products to Report Third Quarter 2019 Financial Results PR Newswire
Oct-24-19 12:15PM	Did Hedge Funds Drop The Ball On China Biologic Products Holdings, Inc. (CBPO) ? Insider Monkey
Oct-17-19 08:00AM	China Biologic Special Committee Retains Financial Advisor and Legal Counsel PR Newswire
Oct-04-19 08:00PM	Tegna, First United, Alico, and Other 13D Filings Barrons.com
Sep-24-19 08:00AM	China Biologic Forms Special Committee to Review "Going Private" Proposal PR Newswire
Sep-19-19 07:39AM	The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO Benzinga +10.52%
06:22AM	China Biologic Shares Soar on Go-Private Takeover Bid TheStreet.com
Sep-18-19 11:19PM	UPDATE 1-China Biologic receives offer to be taken private at $120 a share Reuters
05:36PM	China Biologic receives $4.59 bln take-private buyout offer Reuters
04:01PM	China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal PR Newswire
Aug-29-19 05:31PM	5 Guru Stocks With Predictable Businesses GuruFocus.com
Aug-06-19 11:23PM	China Biologic Products Inc (CBPO) Q2 2019 Earnings Call Transcript Motley Fool
05:30AM	China Biologic Products Holdings, Inc. to Host Earnings Call ACCESSWIRE
Aug-05-19 04:30PM	China Biologic Reports Financial Results for the Second Quarter of 2019 PR Newswire
Jul-26-19 04:30PM	China Biologic Products to Report Second Quarter 2019 Financial Results PR Newswire
May-13-19 12:23PM	China Biologic Products Inc (CBPO) Q1 2019 Earnings Call Transcript Motley Fool
May-10-19 05:45PM	China Biologic Products (CBPO) Tops Q1 Earnings and Revenue Estimates Zacks
04:41PM	China Biologic Products: 1Q Earnings Snapshot Associated Press
04:30PM	China Biologic Reports Financial Results for the First Quarter of 2019 PR Newswire
May-03-19 10:30AM	Earnings Preview: China Biologic Products (CBPO) Q1 Earnings Expected to Decline Zacks -5.58%
Apr-30-19 08:00AM	China Biologic Products to Report First Quarter 2019 Financial Results PR Newswire
Apr-27-19 09:07AM	Is China Biologic Products Inc (CBPO) A Good Stock To Buy According To Hedge Funds? Insider Monkey
Apr-26-19 10:30AM	Analysts Estimate China Biologic Products (CBPO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-09-19 07:26AM	New Strong Sell Stocks for April 9th Zacks
Apr-04-19 09:19AM	New Strong Sell Stocks for April 4th Zacks
Mar-22-19 04:10AM	New Strong Sell Stocks for March 22nd Zacks
Mar-20-19 07:23AM	New Strong Sell Stocks for March 20th Zacks
Mar-18-19 10:47AM	New Strong Sell Stocks for March 18th Zacks
Mar-07-19 03:21PM	China Biologic Products Inc (CBPO) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-06-19 05:00PM	China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 PR Newswire
Feb-25-19 08:00AM	China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
Feb-04-19 01:06PM	Dalton Investments Return, AUM, and Holdings Insider Monkey
Jan-07-19 08:00AM	China Biologic Reiterates Full Year 2018 Financial Forecast PR Newswire
Dec-17-18 10:05AM	David Gao Issues Statement Following Decision by the Grand Court of the Cayman Islands Business Wire
Dec-14-18 08:00AM	China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire -6.50%
Dec-13-18 06:55AM	Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings ACCESSWIRE
Nov-01-18 07:20PM	China Biologic Products: 3Q Earnings Snapshot Associated Press +5.03%
04:30PM	China Biologic Reports Financial Results for the Third Quarter of 2018 PR Newswire
Oct-24-18 08:00AM	China Biologic Products to Report Third Quarter 2018 Financial Results PR Newswire -5.65%
Oct-04-18 12:48PM	Investor Criticizes China Biologic Over Rejected Takeover Bid Bloomberg
Sep-26-18 07:50AM	Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Sep-24-18 09:44AM	Is China Biologic Products Inc. (CBPO) A Good Stock To Buy? Centurium Capital Thinks So Insider Monkey
Aug-29-18 11:59AM	David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders Best Interests Business Wire
Aug-28-18 05:00PM	China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire
Aug-24-18 01:47PM	China Biologic rejects $3.9 bln bid from former CEO Reuters -15.85%
12:35PM	Leading Investor Group Issues Statement Following China Biologics Dilutive Private Placement of Shares Business Wire
11:43AM	[$$] China Biologic Says One Buyout Offer Is Withdrawn, Rejects Another The Wall Street Journal
11:26AM	Here's Why China Biologic Products Stock Dropped Today Motley Fool
10:43AM	BRIEF-PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln Reuters
08:17AM	China Biologic rejects former CEO-led consortium's offer Reuters
08:00AM	China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement PR Newswire
Aug-21-18 04:05PM	Deals of the day-Mergers and acquisitions Reuters
08:00AM	Today's Research Reports on Trending Tickers: Cronos and China Biologic Products ACCESSWIRE
08:00AM	China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal PR Newswire
04:46AM	China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
Aug-20-18 01:52PM	Here's Why China Biologic Products Stock Is Soaring Today Motley Fool +8.71%
01:35PM	China Biologic gets $3.9 billion offer from former CEO-led consortium Reuters
12:26PM	UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
08:38AM	Consortium seeks to acquire China Biologic Products for $3.9 billion in cash MarketWatch
08:30AM	Leading Investor Group Proposes to Acquire China Biologic Products for US$118.00 Per Share in Cash Business Wire
Aug-13-18 08:00AM	China Biologic Names Bing Li as New CEO PR Newswire
Aug-03-18 04:40PM	China Biologic Products: 2Q Earnings Snapshot Associated Press
04:30PM	China Biologic Reports Financial Results for the Second Quarter of 2018 PR Newswire
Jul-27-18 08:00AM	China Biologic Products to Report Second Quarter 2018 Financial Results PR Newswire
Jul-10-18 02:31AM	Ping An Said to Mull Rival Takeover Offer for China Biologic Bloomberg +6.57%
Jul-02-18 08:30AM	China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders PR Newswire
Jun-22-18 02:47AM	Ex-Warburg Pincus China head targets up to $1.5 bln for China fund - sources Reuters

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, auto-immune deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience